Barkey Holding GmbH and its subsidiaries (“Barkey”) have been sold to Azenta Life Sciences (“Azenta”). Based in Leopoldshöhe, Germany, Barkey is a leading provider of controlled rate thawing devices to medical, biotech and pharma industries.
Barkey has over four decades of expertise in the automated thawing of plasma, blood and stem cells and has more recently focused on cell and gene therapy (CGT) applications. Its key product lines are used for controlled rate thawing of cryopreserved samples and therapies. These products are used in R&D, clinical trials, GMP manufacturing and in hospitals. Barkey’s plasmatherm product is an automated cell thawing device approved by the FDA as a medical device for clinical use.
EC M&A acted as exclusive financial advisor to Barkey on this transaction.